Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 18 February 2021


19 Conversations | The EFPIA podcast series

By Catherine Boudot, Director of the Trademark Department at Servier

Today we're asking Catherine Boudot, Director of the Trademark Department at Servier:

"Fighting the fakes - what's industry's role?"

Read more




Pragmatic Solutions Needed for Lifecycle Management of Drug-Device Combinations (Guest Blog)...
18 February 2021 - Amanda Matthews

May 26, 2021 is the fast approaching date of application of the Medical Devices Regulation and with it, the requirement... Read more

What’s next in diabetes care - 100 years since the lifesaving discovery of insulin (Guest blog)...
18 February 2021 - Elvera Laanen Larsen - Yulia Ivanova

The discovery of insulin in 1921 marked the start of a medical journey that has fundamentally changed the lives of people... Read more

Ready for take-off – The launch of Europe’s Beating Cancer Plan (Guest blog)
18 February 2021 - Alexander Roediger

What should we aim for by 2030? Read more




Unlocking the Potential of Precision Medicine in Europe
23 February 2021 (Virtual Event)

How to improve cancer care through broader access to quality biomarker testing Read more

EURORDIS Black Pearl Awards
24 February 2021 (Virtual Event)

Taking place in February to mark the occasion of Rare Disease Day, the EURORDIS Black Pearl Awards celebrate the inspirational... Read more

Blueprint for Action on Diabetes in the European Union by 2030
25 February 2021 (Virtual Event)

MEPs Mobilising for Diabetes Webinar Read more

Decentralised Patient-Centric Trials: From Theory to Practice
18 March 2021 (Virtual / Brussels)

Are remote trials the future? Take a deep dive into patient-centric decentralised trial conduct and explore how these... Read more



Vaccination in time of pandemic, let’s not forget the essential!

Vaccines Europe, 11 February 2021

With COVID-19 pandemic, we should have learned that more than ever, all vaccines play a crucial role in public health and that, vaccines are an incredibly successful and cost-effective public health tool. Read more


What we are reading


The AMR Action Fund announces its first non-industry investments
On 18 February 2021 (AMR action fund)

The AMR Action Fund announces its first non-industry investments, raising an additional US$140 million toward addressing... Read more

EMSP Project Coordinator | Full-time position offer
On 18 February 2021 (European Multiple Sclerosis Platform)

EMSP are looking for a Project Coordinator to join their team and to develop and coordinate EMSP projects, as well as... Read more

Pandemic showcases Belgium as Europe’s Vaccine Valley
On 12 February 2021 (Euractiv)

A small country with an outsize reputation in research and pharmaceuticals, Belgium has emerged with a strategic role... Read more

Ireland is open: The biologics boom boosting the Irish economy
On 12 February 2021 (pharmaphorum)

The life sciences industry has an important role in the Irish economy, with sectors such as biologics booming across... Read more

Pharma industry catalyst for a sustainable & resilient healthcare system in Greece
On 03 February 2021 (The Parliament Magazine)

SFEE and its member companies are committed to ensuring the sustainability of our healthcare systems by breaking barriers... Read more